文献速递乳腺癌放疗放疗物理与技术

乳腺癌根治术后放疗技术的心肺保护:光子与质子在自由呼吸与深吸气屏气下的剂量学比较

Postmastectomy radiation therapy technique and cardiopulmonary sparing: A dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold.
PubMed 文献 · Pract Radiat Oncol · 2017-06-21

所有技术靶区覆盖相似,质子计划均匀性和心肺保护均优于光子DIBH,且质子治疗加DIBH未带来显著剂量学获益。

要点

  • 质子(被动散射或笔束扫描)较光子DIBH改善均匀性和心肺保护,靶区覆盖不劣。
  • 质子计划无论FB或DIBH,心脏和肺剂量指标均优于光子DIBH。
  • 质子治疗加DIBH未显示显著剂量学获益。

核心结论

  • 左乳腺癌根治术后放疗中,质子(被动散射或笔束扫描)无论是否联合DIBH,均较光子部分宽切线联合DIBH改善均匀性和心肺保护,且不牺牲靶区覆盖;质子治疗加DIBH未提供显著剂量学获益。

研究设计与样本

  • 每例患者完成4种计划:光子部分宽切线(DIBH)、被动散射质子(FB)、笔束扫描质子(FB)、笔束扫描质子(DIBH)。
  • 计划设计目标为95%处方剂量覆盖95%胸壁和区域淋巴结,同时最大程度保护心脏和肺。

主要发现

  • 所有技术靶区覆盖相似,但质子改善均匀性指数和心肺保护(每项指标omnibus P < .0001)。
  • 光子DIBH、被动散射质子FB、笔束扫描质子FB、笔束扫描质子DIBH的平均心脏剂量分别为2.09、0.39、0.98、0.71 GyRBE。
  • 上述四种技术的平均左心室剂量分别为3.72、0.08、0.19、0.21 GyRBE,左心室V20分别为2.73、0.03、0、0%。
  • 上述四种技术的左前降支最大剂量分别为46.14、8.28、4.58、4.63 GyRBE,平均肺剂量分别为13.30、5.74、7.63、7.49 GyRBE,肺V20分别为26.04、12.04、15.18、14.43%。
  • 成对检验证实所有质子计划每项指标均优于光子DIBH;被动散射与笔束扫描质子之间、无论是否加DIBH,均匀性指数和心肺保护均无差异。

临床怎么用

  • 对于心脏解剖不利的左乳腺癌根治术后放疗患者,可优先考虑质子治疗(被动散射或笔束扫描)以改善心肺保护。
  • 质子治疗时加用DIBH未显示额外剂量学获益,临床可结合资源和患者配合度决定。

局限性

  • 原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dosimetric studies have suggested greater cardiopulmonary sparing with protons over photons for left-sided postmastectomy radiation therapy (PMRT). Modern techniques such as deep inspiration breath hold (DIBH) can help spare the heart. This analysis compares photon and proton delivery with and without DIBH. METHODS AND MATERIALS: Ten women with left breast cancer referred for PMRT on a prospective clinical trial with unfavorable cardiac anatomy underwent free breathing (FB) and DIBH computed tomography simulation. A partially wide tangent photon (PWTF) during DIBH, passively scattered proton during FB, pencil-beam scanning (PBS) proton during FB, and PBS proton during DIBH plan was completed for each patient. Plans were designed to achieve 95% prescription dose coverage to 95% of chest wall and regional lymphatics while maximally sparing heart and lungs. RESULTS: All techniques resulted in similar target coverage, although protons improved homogeneity indices and cardiopulmonary sparing (omnibus P < .0001 for each metric). Heart/lung metrics for PWTF with DIBH, scattered protons with FB, PBS protons with FB, and PBS protons with DIBH, respectively, were as follows: mean heart dose (2.09, 0.39, 0.98, 0.71 Gy relative biological effectiveness [RBE]), mean left ventricle dose (3.72, 0.08, 0.19, 0.21 GyRBE), V20 left ventricle (2.73, 0.03, 0, 0%), maximum left anterior descending artery dose (46.14, 8.28, 4.58, 4.63 GyRBE), mean lung dose (13.30, 5.74, 7.63, 7.49 GyRBE), and V20 lung (26.04, 12.04, 15.18, 14.43 %). Pairwise testing confirmed an improvement in each metric with all proton plans compared with PWTF with DIBH; there were no differences in homogeneity indices or cardiopulmonary sparing between passively scattered and PBS protons, regardless of addition of DIBH. CONCLUSIONS: For left-sided PMRT, passively scattered or PBS protons with or without DIBH improves homogeneity and cardiopulmonary sparing without compromise in target coverage compared with PWTF photons with DIBH. Furthermore, the addition of DIBH to proton therapy did not provide a significant dosimetric benefit.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Patel SA, Lu HM, Nyamwanda JA, et al. Postmastectomy radiation therapy technique and cardiopulmonary sparing: A dosimetric comparative analysis between photons and protons with free breathing versus deep inspiration breath hold. Pract Radiat Oncol. 2017. PMID: 28734644. doi:10.1016/j.prro.2017.06.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。